To evaluate the efficacy and safety of benign prostatic obstruction (BPO) surgery in patients with preoperative urinary catheterization. We conducted a multi-institutional retrospective study including all patients who failed a trial without catheter (TWOC) after acute urinary retention (AUR) between January 2017 and January 2019. Patients with neurogenic bladder, prostate cancer, or urethral stricture were excluded from the analysis. Patients underwent either monopolar/bipolar transurethral resection of the prostate (TURP), photoselective vaporization of the prostate (PVP), prostate artery embolization (PAE), open prostatectomy (OP), or endoscopic enucleation. The primary endpoint was 12-month urinary catheter-free survival without using benign prostatic hyperplasia medications. One hundred seventy-one consecutive men (median age: 71 years; median prostate volume: 75 cm) underwent BPO surgery, including 48 (28%) TURP, 62 (36.3%) PVP, 21 (12.3%) endoscopic enucleation, 15 (8.8%) PAE, and 25 (14.6%) OP. The median duration of preoperative urinary catheterization was 69 days (interquartile range 46-125). The 12-month urinary catheter-free survival rate was 84.8% (145/171). Satisfactory voiding returned to 121 patients (70.8%). On backward stepwise multivariable analysis, PVP (odds ratio [OR] 0.27 [0.10-0.69]; = 0.008), PAE (OR 5.27 [1.28-27.75]; = 0.03), endoscopic enucleation (OR 0.08 [0-0.49]; = 0.023), OP (OR 0.10 [0.01-0.57]; = 0.034), Charlson score (OR 1.36 [1.14-1.66]; = 0.001), and number of preoperative TWOC failure (OR 2.53 [1.23-5.51]; = 0.014) were significantly associated with catheter-free survival. In this multi-institutional retrospective study, including patients with preoperative catheterization, the overall success rate of BPO surgery was 70.8% after 1-year follow-up. Compared with TURP, enucleation methods and PVP were associated with better catheter-free survival, whereas PAE was associated with higher risk of AUR recurrence.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/end.2020.0704 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Laparoscopy-assisted peritoneal dialysis catheter placement using a modified minimally invasive approach: A retrospective observational study.
Medicine (Baltimore)
October 2023
Hacettepe University School of Medicine, Urology Department, Ankara, Turkey.
Peritoneal dialysis is a reliable and effective treatment for end-stage kidney disease. However, inadequate catheter insertion can lead to mechanical dysfunction, which remains an unresolved problem. In this study, we present the initial results of a modified laparoscopic approach.
View Article and Find Full Text PDFRetrospective Multicenter Observational Study of Immediate Voiding at End of Urinary Sphincter Surgery (REMOVE).
J Urol
December 2023
James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Purpose: Patients may remain catheterized after artificial urinary sphincter surgery to prevent urinary retention, despite a lack of evidence to support this practice. Our study aims to evaluate the feasibility of outpatient, catheter-free continence surgery using a multi-institutional database. We hypothesize that between catheterized controls and patients without a catheter, there would be no difference in the rate of urinary retention or postoperative complications.
View Article and Find Full Text PDFLong-term outcomes of prostate artery embolization for acute urinary retention: An analysis of 88 patients.
Diagn Interv Imaging
June 2023
Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou Vascular and Oncological Interventional Radiology Department, 75015 Paris, France; Université Paris Cité, 75006 Paris, France; HeKA team, INRIA, 75015 Paris, France.
Purpose: The purpose of this study was to assess long-term outcome of prostate artery embolization (PAE) in patients presenting with acute urinary retention related to benign prostatic hyperplasia.
Materials And Methods: All consecutive patients who underwent PAE for acute urinary retention due to benign prostatic hyperplasia from August 2011 to December 2021 in a single institution were retrospectively included. There were 88 men with a mean age of 72 ± 12 (standard deviation [SD]) years (range: 42-99 years).
Clinical outcomes of image-guided percutaneous drainage of pericardial effusion in cancer patients: A single-center retrospective analysis.
Asia Pac J Clin Oncol
February 2023
Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.
Article Synopsis
- The study evaluated the outcomes of percutaneous pericardial effusion drainage in 100 cancer patients, focusing on catheter removal and recurrence rates.
- The procedure had a 100% technical success rate and a 99% clinical success rate, with most catheters removed after an average of 6 days, and symptomatic recurrence occurring in 9 patients.
- The median survival for patients was 140 days, indicating that the drainage procedure is effective and safe, providing relief from symptoms while allowing for a significant catheter-free period.
Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer.
Prostate Cancer Prostatic Dis
March 2023
Department of Interventional Radiology, Tianjin Nankai Hospital, Tianjin, 300193, China.
Objectives: To evaluate the safety and efficacy transcatheter arterial chemoembolization (TACE) for the treatment of refractory gross hematuria (RGH) and urinary retention (UR) secondary to localized advanced prostate cancer (PCa).
Patients And Methods: Thirty-two patients (mean age 72.5 years, range 60-89) with advanced PCa-related RGH that failed conventional therapy were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!